HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideaki Matsui Selected Research

Proteasome Endopeptidase Complex (Proteasome)

10/2010Proteasome inhibition in medaka brain induces the features of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideaki Matsui Research Topics

Disease

13Parkinson Disease (Parkinson's Disease)
04/2024 - 04/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
04/2023 - 12/2019
3Parkinsonian Disorders (Parkinsonism)
12/2020 - 05/2005
2Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 12/2013
2Gaucher Disease (Gaucher's Disease)
01/2022 - 04/2015
2Movement Disorders (Movement Disorder)
01/2021 - 11/2009
2Dementia (Dementias)
12/2020 - 04/2007
2Paralysis (Palsy)
12/2020 - 03/2012
2Multiple System Atrophy
05/2005 - 04/2005
1Neuroblastoma
12/2023
1Inflammation (Inflammations)
03/2022
1Hypoxia (Hypoxemia)
01/2022
1Ischemia
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Brain Injuries (Brain Injury)
01/2022
1Stroke (Strokes)
01/2022
1Esophageal Achalasia (Megaesophagus)
11/2021
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
11/2021
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
04/2015
1Brain Infarction
07/2007
1Atherosclerosis
07/2007
1Hallucinations (Hallucination)
12/2006
1Constipation
06/2006
1Orthostatic Hypotension (Postural Hypotension)
06/2006
1Cognitive Dysfunction
03/2006
1Multiple Sclerosis
07/2005
1Transverse Myelitis (Necrotizing Myelitis)
07/2005
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2005
1POEMS Syndrome (Syndrome, POEMS)
11/2004

Drug/Important Bio-Agent (IBA)

4SynucleinsIBA
04/2024 - 12/2019
33-Iodobenzylguanidine (Iobenguane)IBA
06/2006 - 04/2005
2Glucosylceramidase (Glucocerebrosidase)IBA
01/2022 - 04/2015
2Phosphotransferases (Kinase)IBA
12/2013 - 02/2010
2Proteins (Proteins, Gene)FDA Link
05/2013 - 11/2004
2Inosine Monophosphate (IMP)IBA
04/2007 - 12/2006
2SteroidsIBA
03/2006 - 07/2005
1Etoposide (VP 16)FDA LinkGeneric
12/2023
1Mitochondrial DNA (mtDNA)IBA
12/2022
1DNA (Deoxyribonucleic Acid)IBA
03/2022
1Oxygen (Dioxygen)IBA
01/2022
1deoxyribonuclease II (DNASE II)IBA
01/2021
1Levodopa (L Dopa)FDA LinkGeneric
12/2020
1alpha-SynucleinIBA
04/2015
1P-type ATPasesIBA
05/2013
1Therapeutic UsesIBA
03/2012
1TunicamycinIBA
12/2010
1Ammonium Chloride (Sal Ammoniac)FDA Link
12/2010
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2010
1UbiquitinIBA
10/2010
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2009
1NeurotoxinsIBA
11/2009
1AnticoagulantsIBA
07/2007
1Inosine Triphosphate (ITP)IBA
07/2005
1Ticlopidine (Ticlid)FDA LinkGeneric
11/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2004

Therapy/Procedure

6Therapeutics
04/2023 - 11/2004
1Parenteral Nutrition
11/2021
1Splenectomy
07/2005
1Denervation
05/2005